Navigation Links
Experts issue recommendations for evaluating and treating pituitary incidentalomas
Date:4/7/2011

Chevy Chase, MDToday, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

A pituitary incidentaloma is a tumor or lesion on or near the pituitary gland. It is found when a person has an imaging test for an unrelated reason. Doctors call this an "incidental" finding, meaning by chancethus, the name incidentaloma. This surprise finding is not uncommon. In studies of adults who had head imaging with MRI or CT scans for reasons other than pituitary disease, small incidentalomas were present in up to 20 percent of patients.

"Fortunately, incidentalomas are almost always benign and usually do not need surgery," said Pamela Freda, MD, of the Columbia College of Physicians & Surgeons in New York and chair of the task force that authored the CPG. "This new Clinical Practice Guideline makes recommendations for evaluating and treating a patient with a pituitary incidentaloma, and indicating when surgical therapy may be necessary."

Recommendations from the CPG include:

  • A complete history and physical examination, including a visual field examination if the lesion is touching the optic nerves, for patients with a pituitary incidentaloma;
  • Clinical assessments, neuro-imaging and visual field examinations for patients with pituitary incidentalomas not meeting criteria for surgical removal; and
  • Surgery for patients with pituitary incidentaloma if the tumor is leading to visual abnormalities, stroke-like damage to the pituitary gland (also known as a pituitary apoplexy) or if the tumor itself is producing excess hormones other than prolactin.

The Hormone Foundation, the patient education affiliate of The Endocrine Society, has published a companion patient guide to this CPG. The patient guide, which can be found online at www.hormone.org/Resources/upload/Pituitary-Incidentaloma-Web.pdf, defines the different types of pituitary incidentalomas, lists the condition's symptoms and explains how incidentalomas are treated and when surgery may be needed.

Other members of The Endocrine Society task force that developed this CPG include: Albert Beckers of CHU de Lige in Belgium; Laurence Katznelson of Stanford University in Calif.; Mark Molitch of the Northwestern Feinberg School of Medicine in Chicago, Ill.; Victor Montori of Mayo Clinic Rochester in Minn.; Kalmon Post of Mount Sinai Medical Center in New York, N.Y.; and Mary Lee Vance of the University of Virginia Health Science Center in Charlottesville.

The Society established the Clinical Practice Guideline (CPG) Program to provide endocrinologists and other clinicians with evidence-based recommendations in the diagnosis and treatment of endocrine-related conditions. Each CPG is created by a task force of topic-related experts in the field. Task forces rely on scientific reviews of the literature in the development of CPG recommendations. The Endocrine Society does not solicit or accept corporate support for its CPGs. All CPGs are supported entirely by Society funds.


'/>"/>

Contact: Aaron Lohr
alohr@endo-society.org
240-482-1380
The Endocrine Society
Source:Eurekalert

Related medicine news :

1. As CT Scans of Kids Soar, Experts Urge Oversight
2. Sports Gear Should Also Protect Eyes, Experts Say
3. Allowing Organ Donation by People With HIV Could Save Lives, Experts Say
4. U-M experts: Parents trust doctors most when it comes to information about vaccine safety
5. Little Oversight on Ingredients in Senior Dog Food, Experts Say
6. Social Media Has Good and Bad Effects on Kids: Experts
7. Keep Safety in Mind When Cleaning House, Experts Advise
8. Women Should See Ob-Gyn Annually, Experts Say
9. Keep Kids in Rear-Facing Car Seats Until 2, Experts Say
10. Trace Amounts of Radiation Reach California; No Health Risk, Experts Say
11. Radiation risks to health: A joint statement from leading scientific experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... 2017 , ... While EHR data has revolutionized the nursing ... workstation designed to reduce nursing fatigue while enhancing productivity. Based on field experience ... lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. , Nurses ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... VA (PRWEB) , ... February ... ... FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 ... What are the critical reimbursement questions manufacturers should be asking before selecting ...
(Date:2/17/2017)... Church, VA (PRWEB) , ... February 17, 2017 ... ... Implementing the Steps to Prevent a Warning Letter, **An FDAnews Webinar**, Feb. 23, ... , Do manufacturers distinguish between corrective action (CA) and preventive action (PA)? ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  BioDigital, Inc., creators of the ... their 3D body mapping technology with eClinicalWorks, a ... integration will be used to capture and present ... the human body. BioDigital pilots show using a ... also increasing the precision of clinical annotations compared ...
(Date:2/16/2017)... , Feb. 16, 2017 Absorption Systems, ... and medical devices, is pleased to announce that its ... been selected as a winner of the 2017 Executive ... Magazine and recognizes driven executives for their creative ... ethic. The awards ceremony and celebration is on March ...
(Date:2/16/2017)... DaVita Inc. (NYSE: DVA ) today ... 2016. Net income attributable to DaVita Inc. ... $158 million, or $0.80 per share and $880 million, or ... attributable to DaVita Inc. for the quarter and year ended ... $192 million, or $0.98 per share, and $789 million, or ...
Breaking Medicine Technology: